Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 11/20 | 0.54 |
| ▸ | CYSLTR2 | Q9NS75 | 8/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9757177 | 0.83 | CYSLTR1 (0.50) | CYSLTR1CYSLTR2ALOX5GPBAR1 | |
| SCHEMBL9635641 | 0.82 | CYSLTR2 (0.53) | CYSLTR1CYSLTR2ALOX5 | |
| SCHEMBL9757181 | 0.79 | CYSLTR1 (0.56) | CYSLTR1CYSLTR2ALOX5GPBAR1 | |
| SCHEMBL9757107 | 0.74 | GPBAR1 (0.51) | CYSLTR1CYSLTR2ALOX5GPBAR1 | |
| SCHEMBL9635557 | 0.74 | CYSLTR2 (0.51) | CYSLTR1CYSLTR2ALOX5 | |
| SCHEMBL9757161 | 0.74 | CYSLTR1 (0.54) | CYSLTR1CYSLTR2ALOX5GPBAR1 | |
| SCHEMBL9636955 | 0.73 | CYSLTR2 (0.54) | CYSLTR1CYSLTR2ALOX5 | |
| SCHEMBL9022221 | 0.72 | CYSLTR1 (0.67) | CYSLTR1CYSLTR2ALOX5GPBAR1 | |
| SCHEMBL6088484 | 0.72 | CYSLTR1 (0.69) | CYSLTR1CYSLTR2ALOX5GPBAR1 | |
| SCHEMBL7711072 | 0.71 | GPBAR1 (0.80) | CYSLTR1CYSLTR2ALOX5GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991019475-A2 | QUINOLINYL-BENZOHETEROBICYCLIC DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-12-26 | — | — | WO | disclosed |
| US-5041453-A | Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-08-20 | — | — | US | disclosed |